PetMed Express director reports no PETS holdings

New director Tamar Elkeles filed an initial Form 3 for PETS with no reported share or option holdings.

Available on EDGAR 09/21/2026 - 08:55 AM EDT Accepted by SEC EDGAR 09/21/2026 - 08:55 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

PETMED EXPRESS INC (PETS) reported the initial insider holdings of Tamar Elkeles as a director on a Form 3. The filing lists no reportable transactions, acquisitions, or dispositions of PETS securities and shows no derivative positions or post-transaction holdings, serving solely as an initial ownership disclosure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filed for PETS disclose about Tamar Elkeles?

The Form 3 for PETMED EXPRESS INC (PETS) discloses that Tamar Elkeles is a director of the company and serves as her initial statement of beneficial ownership, with no reportable share or option positions listed.

Does the PETS Form 3 show any stock transactions by Tamar Elkeles?

No. The PETS Form 3 shows no reported transactions, with buy, sell, acquire, dispose, and other transaction counts all at zero and no derivative transactions or holdings disclosed.

Are any PETS shares or derivatives reported as held by Tamar Elkeles on this Form 3?

No. The Form 3 indicates no reported holdings, with holding entries, derivative positions, and post-transaction share balances all showing zero or no entries for PETS securities.

Is there any Rule 10b5-1 trading plan disclosed in the PETS Form 3?

No. The Form 3’s trading-plan indicator is null, meaning it does not state that transactions were made under a Rule 10b5-1 plan, and there are no transactions in the filing.

What insider role does Tamar Elkeles have at PETMED EXPRESS INC (PETS)?

Tamar Elkeles is reported as a director of PETMED EXPRESS INC on the Form 3. She is not identified as an officer or ten percent owner in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Elkeles Tamar

(Last) (First) (Middle)

C/O PETMED EXPRESS, INC.

420 SOUTH CONGRESS AVENUE

(Street)

DELRAY BEACH FLORIDA 33445

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/17/2026

3. Issuer Name and Ticker or Trading Symbol
PETMED EXPRESS INC [ PETS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned.

	/s/ Tamar Elkeles	09/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)